Effect of intrathecal FK506 administration on intraorbital optic nerve crush: An ultrastructural study

Canadian Journal of Ophthalmology

Volumn 44, Issue 4, 2009, Pages 427-430

  Sarikcioglu, Levent ^a   Demir, Necdet ^a   Akar, Yusuf ^a   Demirtop, Arife ^a  

^a AKDENIZ UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Crush injury; FK506; Intrathecal administration; Optic nerve; Protection

Indexed keywords

MYELIN; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATHETERIZATION; CONTROLLED STUDY; DRUG DOSE REGIMEN; ELECTRON MICROSCOPY; FEMALE; IMMUNOSUPPRESSIVE TREATMENT; LOW DRUG DOSE; MICROSCOPY; NERVE CRUSH; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OPTIC NERVE FIBER; OPTIC NERVE INJURY; POSTOPERATIVE PERIOD; QUALITATIVE ANALYSIS; RAT; ULTRASTRUCTURE; WISTAR RAT;

EID: 68149149682     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.3129/i09-071     Document Type: Article

References (28)

1. Kino T, Hatanaka H, Miyata S, et al. FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J Antibiot (Tokyo) 1987;40:1256-1265 (Pubitemid 17138110)
2. Goto T, Kino T, Hatanaka H, et al. Discovery of FK-506, a novel immunosuppressant isolated from Streptomyces tsukubaensis. Transplant Proc 1987;19:4-8. (Pubitemid 17157071)
3. Kawashima H, Fujino Y, Mochizuki M. Effects of a new immunosuppressive agent, FK506, on experimental autoimmune uveoretinitis in rats. Invest Ophthalmol Vis Sci 1988;29:1265-1271 (Pubitemid 18200748)
4. Sakurai E, Nozaki M, Okabe K, Kunou N, Kimura H, Ogura Y. Scleral plug of biodegradable polymers containing tacrolimus (FK506) for experimental uveitis. Invest Ophthalmol Vis Sci 2003;44:4845-4852 (Pubitemid 37315299)
5. Brazis PW, Spivey JR, Bolling JP, Steers JL. A case of bilateral optic neuropathy in a patient on tacrolimus (FK506) therapy after liver transplantation. Am J Ophthalmol 2000;129:536-8.
6. Lake DB, Poole TR. Tacrolimus. Br J Ophthalmol 2003;87:121-122
7. Mochizuki M, Masuda K, Sakane T, et al. A clinical trial of FK506 in refractory uveitis. Am J Ophthalmol 1993;115:763-769 (Pubitemid 23171604)
8. Sloper CM, Powell RJ, Dua HS. Tacrolimus (FK506) in the treatment of posterior uveitis refractory to cyclosporine. Ophthalmology 1999;106:723-728
9. Gellrich NC, Schimming R, Zerfowski M, Eysel UT. Quantification of histological changes after calibrated crush of the intraorbital optic nerve in rats. Br J Ophthalmol 2002;86:233-237 (Pubitemid 34127551)
10. Berry M, Bannister LH, Starding SM. Nervous system. In: Williams PLT, Bannister LH, Berry M, et al., eds. Gray's Anatomy. New York, N.Y.: Churchill Livingstone; 1995:1225-1226
11. Sarikcioglu L, Demir N, Demirtop A. A standardized method to create optic nerve crush: Yasargil eneurysm clip. Exp Eye Res 2007;84:373-377 (Pubitemid 44958474)
12. Campbell G, Holt JK, Shotton HR, Anderson PN, Bavetta S, Lieberman AR. Spontaneous axonal regeneration after optic nerve injury in adult rat. Neuroreport 1999;10:3955-3960 (Pubitemid 30004863)
13. Bavetta S, Hamlyn PJ, Burnstock G, Lieberman AR, Anderson PN. The effects of FK506 on dorsal column axons following spinal cord injury in adult rats: neuroprotection and local regeneration. Exp Neurol 1999;158:382-393 (Pubitemid 29382828)
14. Fansa H, Keilhoff G, Altmann S, Plogmeier K, Wolf G, Schneider W. The effect of the immunosuppressant FK 506 on peripheral nerve regeneration following nerve grafting. J Hand Surg [Br] 1999;24:38-42. (Pubitemid 29084344)
15. Feng FY, Ogden MA, Myckatyn TM, et al. FK506 rescues peripheral nerve allografts in acute rejection. J Neurotrauma 2001;18:217-229
16. Freeman EE, Grosskreutz CL. The effects of FK506 on retinal ganglion cells after optic nerve crush. Invest Ophthalmol Vis Sci 2000;41:1111-1115 (Pubitemid 30187548)
17. Gold BG, Katoh K, Storm-Dickerson T. The immunosuppressant FK506 increases the rate of axonal regeneration in rat sciatic nerve. J Neurosci 1995;15:7509-7516
18. Grosskreutz CL, Hanninen VA, Pantcheva MB, Huang W, Poulin NR, Dobberfuhl AP. FK506 blocks activation of the intrinsic caspase cascade after optic nerve crush. Exp Eye Res 2005;80:681-686 (Pubitemid 40602969)
19. Jost SC, Doolabh VB, Mackinnon SE, Lee M, Hunter D. Acceleration of peripheral nerve regeneration following FK506 administration. Restor Neurol Neurosci 2000;17:39-44. (Pubitemid 30822303)
20. Wang MS, Zeleny-Pooley M, Gold BG. Comparative dosedependence study of FK506 and cyclosporin A on the rate of axonal regeneration in the rat sciatic nerve. J Pharmacol Exp Ther 1997;282:1084-1093 (Pubitemid 27340215)
21. Gold BG. FK506 and the role of immunophilins in nerve regeneration. Mol Neurobiol 1997;15:285-306. (Pubitemid 127720199)
22. Gustafsson LL, Wiesenfeld-Hallin Z. Spinal opioid analgesia. A critical update. Drugs 1988;35:597-603. (Pubitemid 18184698)
23. Lamer TJ. Treatment of cancer-related pain: when orally administered medications fail. Mayo Clin Proc 1994;69:473-480 (Pubitemid 24132693)
24. Gillon RS, Cui Q, Dunlop SA, Harvey AR. Effects of immunosuppression on regrowth of adult rat retinal ganglion cell axons into peripheral nerve allografts. J Neurosci Res 2003;74:524-532 (Pubitemid 37352074)
25. Okada K, Sakata H, Minamoto A, Fujihara M. Effect of FK 506 administered topically versus intramuscularly on suppression of the corneal immune reaction in rats. Ophthalmologica 1996;210:175-179 (Pubitemid 26153573)
26. Akar Y, Yucel G, Durukan A, Yucel I, Arici G. Systemic toxicity of tacrolimus given by various routes and the response to dose reduction. Clin Experiment Ophthalmol 2005;33:53-59 (Pubitemid 40330976)
27. Rosenstiel P, Schramm P, Isenmann S, et al. Differential effects of immunophilin-ligands (FK506 and V-10,367) on survival and regeneration of rat retinal ganglion cells in vitro and after optic nerve crush in vivo. J Neurotrauma 2003;20:297-307. (Pubitemid 36373827)
28. Sarikcioglu L, Duygulu E, Aydin H, Gurer EI, Ozkan O, Tuzuner S. Effect of intrathecal administration of FK506 after sciatic nerve crush injury. J Reconstr Microsurg 2006;22:649-654